• LAST PRICE
    0.7199
  • TODAY'S CHANGE (%)
    Trending Up0.0099 (1.3942%)
  • Bid / Lots
    0.7000/ 6
  • Ask / Lots
    0.7300/ 5
  • Open / Previous Close
    0.6887 / 0.7100
  • Day Range
    Low 0.6600
    High 0.7277
  • 52 Week Range
    Low 0.3503
    High 3.0500
  • Volume
    49,864
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.71
TimeVolumeYS
09:32 ET2380.6887
09:50 ET27640.6677
09:52 ET5000.6884
09:54 ET4620.6884
10:01 ET4530.6884
10:08 ET3430.7
10:10 ET27550.675
10:12 ET1000.6855
10:14 ET1680.679
10:30 ET1200.690684
10:44 ET9900.6911
10:53 ET1000.695
10:57 ET4500.695
11:04 ET1000.695101
11:33 ET7000.7034
11:40 ET4500.6951
12:02 ET2000.7003
12:05 ET3000.7012
12:07 ET5000.7003
12:25 ET4500.71
12:32 ET1000.7007
12:34 ET59340.71
12:36 ET1000.71885
12:50 ET1750.7123
01:03 ET4380.7137
01:10 ET1500.72
01:21 ET21000.72
01:33 ET24700.71
01:37 ET1000.71
01:46 ET6510.71
02:06 ET3000.6951
02:15 ET1000.71
02:24 ET6000.709999
02:56 ET1400.71
03:02 ET1990.7001
03:03 ET1000.7
03:05 ET1040.7
03:09 ET34880.6979
03:48 ET20620.72
03:50 ET2000.709999
03:57 ET71080.71
03:59 ET50000.719899
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesYS
YS Biopharma Co Ltd
135.6M
-1.3x
---
United StatesGTH
Genetron Holdings Ltd
127.3M
-0.4x
---
United StatesTCON
TRACON Pharmaceuticals Inc
19.6M
-1.7x
---
United StatesJAGX
Jaguar Health Inc
21.0M
0.0x
---
United StatesEIGR
Eiger BioPharmaceuticals Inc
7.4M
-2.6x
---
United StatesMCUJF
Medicure Inc
8.9M
11.2x
-27.07%
As of 2024-03-29

Company Information

YS Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.

Contact Information

No data available

Executives

Chairman of the Board
Yi Zhang
President, Chief Executive Officer, Director
Hui Shao
Chief Financial Officer
Chunyuan Wu
Head of Marketing and sales
Gang Li
Head of vaccine research
Yuan Liu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$135.6M
Revenue (TTM)
$77.6M
Shares Outstanding
188.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.56
Book Value
$1.08
P/E Ratio
-1.3x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
---
Operating Margin
-54.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.